![]() |
Photo Credit: Claudio_Scott |
The results of the analysis, part of the European Prevention of Alzheimer's Dementia Longitudinal Cohort Study (EPAD LCS), indicate that poor sleep quality is related to an increase in pathology of Alzheimer's disease. This finding is relevant to help define future therapies, so that they can be targeted at the appropriate phase of the disease.
A cross-sectional analysis of sleep quality
Sleep abnormalities are common in Alzheimer's disease, and sleep quality can be affected early in the preclinical stage of the disease, even when no other symptoms are experienced. Understanding how and when sleep deprivation contributes to Alzheimer's disease progression is important for the design and implementation of future therapies.
Laura Stankeviciute, a predoctoral researcher at the BBRC and one of the main authors of the study, said: "The epidemiological and experimental data available to date already suggested that sleep abnormalities contribute to the risk of Alzheimer's disease.
"However, previous studies had limitations due to the lack of biomarkers of Alzheimer's disease, because they had a non-cross-sectional design, or because of the small size of the sample of participants.” This is the first study to include all of these factors.